Michael Van Vleck
Chief Executive Officer
Phyto-Riker Pharmaceuticals

Mr. Van Vleck is a senior executive with a proven track record of developing, building and managing successful ventures. He has extensive worldwide transactional and general management experience with a broad multi-functional background, including finance, strategic planning, marketing/communications and management. He has graduated from the University of Pennsylvania, with an M.A. in International Studies and an M.B.A. from the Wharton School, and from the University of New Hampshire with a B.S. in Business Administration.

Mr. Van Vleck is currently serving as Chief Executive Officer of Phyto-Riker Pharmaceuticals Ltd. Formerly, Mr. Van Vleck directed the investment program of a private equity healthcare fund focused on product manufacturing and service provision companies located in Africa, Latin America and Asia.

Prior to that, Mr. Van Vleck helped, founded and built two fiber optic telecommunications companies, Global Fiber Group and Cogent Communications serving in the roles of President and Vice President of Marketing and Strategy, respectively. Before that, Mr. Van Vleck founded and ran his own consulting company for seven years where he represented large U.S. energy, telecommunications and healthcare companies including ATT, Primus, Deutsche Telecom, Unocal, Cogentrix in matters relating to business development, marketing and finance.

He began his career in the investment business with the New York LBO firm of Acadia Partners, where he sought enhanced equity returns by investing in operating companies in various industries.

Return to: CPTech Home | Workshop on Improving Accessibility of Drugs